Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
Status:
Completed
Trial end date:
2010-09-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test the hypothesis that the efficacy and safety of
Meditoxin® are not inferior to Botox®'s in the treatment of glabellar lines.
Phase:
Phase 3
Details
Lead Sponsor:
Medy-Tox
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA